Figure 3.
Figure 3. Cumulative incidence of TRM. (A) TRM for all patients was 11% (n = 29) at 1 year and 15% at 3 years. (B) TRM for patients with MRDs was 10% at 1 year and 22% at 3 years (n = 11) vs 11% at 1 year and 3 years for MUD/MMUD transplants (n = 18; P = .536). (C) TRM for patients with CGD was 10% at 1 year and at 3 years (n = 11) vs other PID 12% at 1 year and 3 years (n = 18; P = .73).

Cumulative incidence of TRM. (A) TRM for all patients was 11% (n = 29) at 1 year and 15% at 3 years. (B) TRM for patients with MRDs was 10% at 1 year and 22% at 3 years (n = 11) vs 11% at 1 year and 3 years for MUD/MMUD transplants (n = 18; P = .536). (C) TRM for patients with CGD was 10% at 1 year and at 3 years (n = 11) vs other PID 12% at 1 year and 3 years (n = 18; P = .73).

Close Modal

or Create an Account

Close Modal
Close Modal